ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "Diagnostic Tests"

  • Abstract Number: 1334 • 2016 ACR/ARHP Annual Meeting

    Contribution of Diagnostic Investigations in the Management of Uveitis: Retrospective Analysis of 300 Patients

    Jérôme Hadjadj1, Thibault Chapron2, Manal Assala1, Sawsen Salah2, Bertrand Dunogue1, Matthieu Groh3, Philippe Blanche1, Luc Mouthon4, Dominique Monnet2, Claire Le Jeunne4, Antoine Brezin2 and Benjamin Terrier3, 1Internal Medicine, Cochin Hospital, Paris, France, 2Ophtalmology, Cochin Hospital, Paris, France, 3National Referral Center for Rare Systemic Autoimmune Diseases, Hôpital Cochin, AP–HP, Université Paris Descartes, Paris, France, 4Department of Internal Medicine, Referral Center for Rare Autoimmune and Systemic Diseases, Hôpital Cochin, AP–HP, Université Paris Descartes, Paris, France, Paris, France

    Background/Purpose: Uveitis represents a diagnostic and therapeutic challenge, as well as an economic one, due to its heterogeneous presentation, multiple underlying causes and lack of…
  • Abstract Number: 1518 • 2016 ACR/ARHP Annual Meeting

    Immunoglobulin Binding Protein (BiP), an Antigen for CCP Sero-Positive Rheumatoid Arthritis Patients, Can Result in a False Positive Quantiferon-Gold Tuberculosis Test

    JoAnn Ball1, Kelsy Greenwald1, Atul A. Deodhar2 and Kevin L. Winthrop3, 1Rheumatology, Desert Medical Advances, Palm Desert, CA, 2Division of Arthritis & Rheumatic Diseases OP09, Oregon Health & Science University, Portland, OR, 3Oregon Health and Sciences University, Portland, OR

    Background/Purpose: Citrullinated BiP is a newly described target for cyclic citrullinated peptide(CCP).  BiP in both serum and synovial fluid is over-expressed in RA patients and…
  • Abstract Number: 1892 • 2016 ACR/ARHP Annual Meeting

    Immunosignature Technology Differentiates Patients with Systemic Sclerosis and Internal Organ Involvement

    Lorinda Chung1, David Fiorentino2, Robert Gerwien3, Kathleen Jia4, Joseph Barten Legutki3, Antonio Valenzuela Vergara4, Lisa Zhu4, Theodore M. Tarasow3 and Kathryn Sykes3, 1Rheumatology, Stanford University Medical Center, Palo Alto, CA, 2Department of Dermatology, Stanford University School of Medicine, Palo Alto, CA, 3HealthTell, Inc, san ramon, CA, 4Stanford University Medical Center, Palo Alto, CA

    Background/Purpose: Systemic sclerosis (SSc) is a connective tissue disease (CTD) characterized by fibrosis, vascular complications, and inflammation affecting both skin and internal organs. Diagnosis of…
  • Abstract Number: 1902 • 2016 ACR/ARHP Annual Meeting

    Detecting the Pulmonary Vascular Involvement and the Changes in Gene Activation Profiles at Early Stage of Systemic Sclerosis in Patients with Raynaud Phenomenon

    Yoshinobu Koyama1, Soichiro Fuke2, Yoshiharu Sato3 and Toshie Higuchi4, 1Division of Rheumatology, Japan Red Cross Okayama Hospital, Okayama, Japan, 2Department of Cardiology, Japan Red Cross Okayama Hospital, Okayama, Japan, 3DNA Chip Research Inc, Yokohama, Japan, 4Center for Autoimmune Diseases, Division of Rheumatology, Japan Red Cross Okayama Hospital, Okayama, Japan

    Background/Purpose: Raynaud phenomenon (RP) is known to precede other disease manifestations of systemic sclerosis (SSc), and classically viewed as reversible vasospasm due to functional changes…
  • Abstract Number: 1926 • 2016 ACR/ARHP Annual Meeting

    Indications for Testing and Diagnostic Outcome in Patients with Positive ANCA at a Canadian Tertiary Care Centre

    Cyrus Chehroudi1,2, Ronald Booth3,4 and Nataliya Milman4,5,6, 1Rheumatology, The Ottawa Hospital, Ottawa, ON, Canada, 2Medicine, University of Ottawa, Ottawa, ON, Canada, 3Division of Biochemistry, The Ottawa Hospital, Ottawa, ON, Canada, 4Department of Clinical Epidemiology, Ottawa Hospital Research Institute, Ottawa, ON, Canada, 5Department of Medicine, University of Ottawa, Ottawa, ON, Canada, 6Division of Rheumatology, The Ottawa Hospital, Ottawa, ON, Canada

    Background/Purpose: Anti-neutrophil cytoplasmic antibodies (ANCA) are a hallmark of a subset of small vasculitides collectively termed ANCA-associated vasculitis (AAV). With widespread availability of ANCA testing,…
  • Abstract Number: 2007 • 2016 ACR/ARHP Annual Meeting

    Sensitivity and Specificity of Autoantibodies Against CD74 in Early Axial Spondyloarthritis

    Torsten Witte1, Elke Riechers2, Niklas Thomas Baerlecken3, Xenofon Baraliakos4, Katrin Achilles-Mehr Bakhsh5, Peer Aries6, Bettina Bannert7, Klaus Becker8, Jan Brandt-Juergens9, Juergen Braun10, Boris P. Ehrenstein11, Hartwig Euler12, Martin Fleck13, Reinhard Hein14, Kirsten Karberg15, Lars Koehler16, Torsten Matthias17, Regina Max18, Adelheid Melzer19, Dirk Meyer-Olson20, Juergen Rech21, Karin Rockwitz22, Martin Rudwaleit23, Eva Schweikhard17, Joachim Sieper24, Carsten Stille16, Ulrich von Hinüber25, Peter Wagener26, Heike Weidemann27 and Silke Zinke15, 1Clinic for Immunology and Rheumatology, Hannover Medical School, Hannover, Germany, 2Medical University Hannover, Hannover, Germany, 3Clinical Immunology and Rheumatology, MD, Hannover, Germany, 4Rheumazentrum Ruhrgebiet Herne, Ruhr-University Bochum, Herne, Germany, 5Rheumatology, Hannover, Hannover, Germany, 6Rheumatologie im Struenseehaus, Hamburg, Germany, 7Department of Internal Medicine, Clinic for Rheumatology and Clinical Immunology, Freiburg, Germany, 8Rheumapraxis Blaubeuren, Blaubeuren, Germany, 9Praxis Brandt-Juergens/Karberg, Berlin, Germany, 10Rheumazentrum Ruhrgebiet, Herne, Germany, 11Department of Rheumatology/Clinical Immunology, Asklepios Medical Center, 93077 Bad Abbach, Germany, 12Rheumapraxis Hamburg, Hamburg, Germany, 13Department of Internal Medicine I, University of Regensburg, 93042 Regensburg, Germany, 14Rheumapraxis Nienburg, Nienburg, Germany, 15Rheumapraxis, Berlin, Germany, 16Rheumapraxis, Hannover, Germany, 17Aesku.Diagnostics, Wendelsheim, Germany, 18Dept. of Internal Medicine 5, Division of Rheumatology, University of Heidelberg, Heidelberg, Germany, 19Rheumapraxis, Seesen, Germany, 20m&i Fachklinik Bad Pyrmont, Bad Pyrmont, Germany, 21Department of Internal Medicine 3 – Rheumatology and Immunology, Universitätsklinikum Erlangen, Friedrich-Alexander-University Erlangen-Nürnberg (FAU), Erlangen, Germany, 22Rheumatologic Practice, Goslar, Germany, 23Klinikum Bielefeld Rosenhöhe, Bielefeld, Germany, 24Rheumatology Department, Charité – University Medicine Berlin, Berlin, Germany, 25Rheumapraxis Hildesheim, Hildesheim, Germany, 26Rheumapraxis, Nienburg, Germany, 27Rheumapraxis Hannover, Hannover, Germany

    Background/Purpose:   Making the diagnosis of axial spondyloarthritis (axSpA) may be difficult. Antibodies against CD74 have been shown to be present in 2/3 of patients…
  • Abstract Number: 2075 • 2016 ACR/ARHP Annual Meeting

    No Detection of Varicella-Zoster Virus in Temporal Arteries of Patients with Giant Cell Arteritis

    Francesco Muratore1, Stefania Croci2, Ione Tamagnini3, Alessandro Zerbini2, Salvatore Bellafiore4, Lucia Belloni5, Luigi Boiardi6, Alessandra Bisagni7, Maria Parmeggiani8, Alberto Cavazza9 and Carlo Salvarani1, 1Rheumatology Unit, Arcispedale S Maria Nuova, IRCCS, Reggio Emilia, Italy, 2Clinical Immunology, Allergy and Advanced Biotechnologies Unit,, Arcispedale S Maria Nuova-IRCCS, Reggio Emilia, Italy, 3Pathology Unit, Department of Oncology, Arsicpedale S Maria Nuova, IRCCS, Reggio Emilia, Italy, 4Pathology Unit, Department of Oncology, Arcispedale S Maria Nuova, Reggio Emilia, Italy, 5Clinical Immunology, Allergy and Advanced Biotechnologies Unit, Arcispedale S Maria Nuova-IRCCS, Reggio Emilia, Italy, 6Rheumatology Unit, Arcispedale S.Maria Nuova, IRCCS, Reggio Emilia, Italy, 7Pathology Unit, Department of Oncology, Arcispedale S Maria Nuova, IRCCS, Reggio Emilia, Italy, 8. Clinical Immunology, Allergy and Advanced Biotechnologies Unit, Arcispedale S Maria Nuova-IRCCS, Reggio Emilia, Italy, 9Pathology Unit, Arcispedale S Maria Nuova-IRCCS, Reggio Emilia, Italy

    Background/Purpose: Recent studies found an high prevalence of varicella-zoster virus (VZV) infection in temporal arteries (TAs) from both temporal artery biopsy (TAB)-positive and TAB-negative giant…
  • Abstract Number: 2800 • 2016 ACR/ARHP Annual Meeting

    Cell-Bound Complement Activation Products in Multi-Analyte Assay with Algorithm Aid the Diagnosis of Systemic Lupus Erythematosus

    James Mossell1, John A. Goldman2, Derren Barken3 and Roberta Alexander4, 1Tift Regional Medical Center, Tifton, GA, 2Medical Quarters #293, Emory St. Joseph’s Hospital, Atlanta, GA, 3Exagen Diagnostics, Vista, CA, 4Research & Development, Exagen Diagnostics, Vista, CA

    Background/Purpose: Cell-bound complement activation products (CB-CAPs) are sensitive and specific biomarkers in the differential diagnosis of systemic lupus erythematosus (SLE) and other rheumatic diseases, as…
  • Abstract Number: 776 • 2015 ACR/ARHP Annual Meeting

    Sensitivity of Antinuclear Antibody By Immunofluorescence Testing for Detection of Anti-Ro/SSA Antibodies

    Ivan Alcantara-Arreola1, Nina Tello-Winniczuk2 and Alejandro Diaz-Borjon3, 1Hospital Angeles Lomas, Huixquilucan, Mexico, 2Division of Internal Medicine / Rheumatology, Hospital Angeles Lomas, Huixquilucan, Mexico, 3Med/Div of Rheumatology, Hospital Angeles Lomas, Huixquilucan, Mexico

    Background/Purpose: A positive ANA test is a diagnostic criterion for several rheumatic diseases, although it may appear in other autoimmune disorders and healthy individuals. An…
  • Abstract Number: 2961 • 2015 ACR/ARHP Annual Meeting

    Reliability and Validity of the Total Joint Count and Swollen Joint Count in Early Diffuse Systemic Sclerosis

    Jessica K. Gordon1, Veronica J. Berrocal2, Gandikota Girish3, Meng Zhang4, Chris Hatzis1, Shervin Assassi5, Elana J. Bernstein6, Robyn T. Domsic7, Faye N. Hant8, Monique E. Hinchcliff9, Elena Schiopu10, Virginia D. Steen11, Tracy M. Frech12 and Dinesh Khanna13, 1Rheumatology, Hospital for Special Surgery, New York, NY, 2Div of Rheumatology, University of Michigan, Ann Arbor, MI, 3Radiology, University of Michigan, Ann Arbor, MI, 4Epidemiology and Biostatistics, Hospital for Special Surgery, New York, NY, 5Rheumatology, University of Texas Medical School at Houston, Houston, TX, 6Rheumatology, Columbia University College of Physicians & Surgeons, New York, NY, 7Medicine - Rheumatology, University of Pittsburgh, Pittsburgh, PA, 8Dept of Medicine, Medical University of South Carolina, Charleston, SC, 9Division of Rheumatology, Division of Rheumatology, Northwestern University, Feinberg School of Medicine, Chicago, IL, 10University of Michigan, Ann Arbor, MI, 11Rheumatology, Georgetown University Medical Center, Washington, DC, 12Div of Rheumatology, University of Utah, Salt Lake City, UT, 13Division of Rheumatology, University of Michigan, Ann Arbor, MI

    Background/Purpose:  Arthropathy and tendinopathy in Systemic Sclerosis (SSc) contribute to disability and are associated with disease progression. Clinical trials in SSc sometimes include the tender…
  • Abstract Number: 777 • 2015 ACR/ARHP Annual Meeting

    SLE-KeyTM Rule-out Test to Assess Lupus in Anti-Nuclear Antibody Positive Subjects Using the Immunarray iCHIP®

    D. Scott Batty1, I.R. Cohen2, Chaim Putterman3, Nicole Jordan4, Keren Jakobi5, Rachel Sorek5, Yakov Blumenstein5, Pennina Safer5 and David Pisetsky6, 1ImmunArray Inc., Richmond, VA, 2Weizmann Institute of Science, Rehovot, Israel, 3Division of Rheumatology, Albert Einstein College of Medicine, Bronx, NY, 4Montefiore Medical Center, New York, NY, 5ImmunArray LTD, Rehovot, Israel, 6Duke University Medical Center and Durham VAMC, Durham, NC

    Background/Purpose: SLE is associated with a broad spectrum of autoantibodies, but currently there is no single serologic test to diagnose SLE definitively.  Diagnosis is thus…
  • Abstract Number: 3127 • 2015 ACR/ARHP Annual Meeting

    Serologic Diagnosis of Human Neuropsychiatric Lupus Using the Immunarray ICHIP®

    Chaim Putterman1, D. Scott Batty2, I.R. Cohen3, Nicole Jordan4, Debbie Rybak1, Tamar Rubinstein1, Keren Jakobi5, Rachel Sorek5, Anat Reiner-Benaim5, Yakov Blumenstein5 and Pennina Safer5, 1Division of Rheumatology, Albert Einstein College of Medicine, Bronx, NY, 2ImmunArray Inc., Richmond, VA, 3Weizmann Institute of Science, Rehovot, Israel, 4Montefiore Medical Center, New York, NY, 5ImmunArray LTD, Rehovot, Israel

    Background/Purpose: Peripheral neurologic syndromes and central nervous system (CNS) manifestations are recognized as primary disease manifestations in systemic lupus erythematosus (SLE). Neuropsychiatric SLE (NPSLE) involves…
  • Abstract Number: 1095 • 2015 ACR/ARHP Annual Meeting

    Identification of Carbamylated Alpha-1-Anti-Trypsin (A1AT) As an Antigenic Target of Anti-Carp Antibodies in Patients with Rheumatoid Arthritis

    Marije K. Verheul1, Alvin Yea2, Andrea Seaman2, Robert A. Cordfunke3, Jan W. Drijfhout4, George M. Janssen4, Arnoud de Ru3, Peter A. van Veelen4, René E. M. Toes5, Michael Mahler2 and Leendert A. Trouw1, 1Department of Rheumatology, Leiden University Medical Center, Leiden, Netherlands, 2Inova Diagnostics, San Diego, CA, 3IHB, Leiden University Medical Center, Leiden, Netherlands, 4Immunohematology and Bloodbank, Leiden University Medical Center, Leiden, Netherlands, 5Leiden University Medical Center, Leiden, Netherlands

    Background/Purpose: Antibodies targeting carbamylated proteins (anti-CarP) were recently identified in serum samples from patients with rheumatoid arthritis (RA). The presence of anti-CarP antibodies was associated…
  • Abstract Number: 1354 • 2015 ACR/ARHP Annual Meeting

    Whipple’s Disease: The Diagnostic Utility of Synovial Fluid Tropheryma Whipplei Polymerase Chain Reaction

    Zoran Kvrgic1, Kelly Cawcutt2, Robin Patel3, Abinash Virk2, Clement J. Michet Jr.4, Eric L. Matteson5 and Tim Bongartz1, 1Rheumatology, Mayo Clinic, Rochester, MN, 2Infectious Diseases, Mayo Clinic, Rochester, MN, 3Medicine, Mayo Clinic, Rochester, MN, 4Mayo Clinic, Rochester, MN, 5Division of Rheumatology, Department of Internal Medicine and Department of Health Sciences Research, Mayo Clinic, Rochester, MN

    Background/Purpose: Inflammatory arthritis is a common, non-specific symptom of Whipple’s disease. Recovery of the organism by conventional culture is often unsuccessful. Synovial fluid polymerase chain…
  • Abstract Number: 1714 • 2015 ACR/ARHP Annual Meeting

    Young Patients with Back Pain and Maximally 1 Spa Feature: Is It Useful to Test HLA-B27 or Image the Sacroiliac Joints?

    Pauline Bakker1, Zineb Ez-Zaitouni2, Miranda van Lunteren2, Manouk de Hooge3, Rosaline van den Berg4, Inger Jorid Berg5, Robert B. M. Landewé6, Maikel van Oosterhout7, Roberta Ramonda8, Monique Reijnierse9, Floris van Gaalen1 and Désirée van der Heijde10, 1Rheumatology, Leiden University Medical Center, Leiden, Netherlands, 2Leiden University Medical Centre, Leiden, Netherlands, 3Department of Rheumatology, Leiden University Medical Centre, Leiden, Netherlands, 4Leiden University Medical Center, Leiden, Netherlands, 5Department of Rheumatology, Diakonhjemmet Hospital, Oslo, Norway, 6Rheumatology, University Hospital Maastricht, Maastricht, Netherlands, 7Rheumatology, GHZ Hospital, Gouda, Netherlands, 8Cattedra, Voc Rheumatology, University of Padua, Padova, Italy, 9Radiology, Leiden University Medical Center, Leiden, Netherlands, 10University Hospital, Maastricht, Netherlands

    Background/Purpose: Axial SpondyloArthritis (axSpA) is a heterogeneous disease. The likelihood of diagnosis varies depending upon the specific findings that are present. However, it is debated…
  • « Previous Page
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • …
  • 8
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology